The 8-hour Buprenorphine Training - PART 1
The 8-hour Buprenorphine Training - PART 1
The 8-hour Buprenorphine Training - PART 1
The 8-hour Buprenorphine Training - PART 1
The 8-hour Buprenorphine Training - PART 1 - 2/11/2023
The 8-hour Buprenorphine Training - PART 1 - 3/11/2023
The 8-hour Buprenorphine Training - PART 1 - 2/27/2023
The 8-hour Buprenorphine Training - PART 1 - 3/27/2023
The 8-hour Buprenorphine Training - PART 1 - 4/8/2023
STUDENT OSTEOPATHIC MEDICAL ASSOCIATION COURSE (SOMA) - The 8-hour Buprenorphine Training PART 1 - 03/04/2023
ORN Spring 2023 - Innovation and Regulation: Improving Methadone Access While Maintaining Treatment Quality and Safety
ORN Spring 2023 - Medicaid Managed Care Coverage for Substance Use Disorder Treatment
ORN Spring 2023 - Why Preventing Drug Overdose Deaths is a Moving Target: Dynamic Shifts to the Opioid Crisis by Age, Race, Supply, Demand, and Geography
ORN Spring 2023 - Reducing Health Harms for People who Inject Drugs in Appalachia - Research and Practice Partnerships in Syringe Service Programs
ORN Spring 2023 - Isn't There a Better Way? Mitigating the Harms of Criminal Legal Involvement for Pregnant People Who Use Drugs
Addressing SUD/MAT in the Emergency Department Setting
Opioid Treatment Programs
Veterans and Active-Duty Military Issues in SUD
Criminal Justice Settings: Buprenorphine & Fentanyl in E.R. and Adult Drug Treatment Courts, Jail and Prison
DEA - Addiction Medicine Essentials Course- AOA/AOAAM
ORN Fall 2023 - Opioid Use Disorder, Depression & Suicide: Overlapping Risk & Treatment Challenges
ORN Fall 2023 - New Approaches to Methamphetamine Addiction and Psychosis
ORN Fall 2023 - Operationalizing a Definition of Precipitated Withdrawal and the Absorption, Distribution, Metabolism, and Elimination of Illicitly Manufactured Fentanyl
ORN Fall 2023 - Xylazine - An Introduction to a New Drug
ORN Fall 2023 - Brixadi (buprenorphine-XR) for the Treatment of Opioid Use Disorder
ORN Fall 2023 - The Evolution of Buprenorphine: Prescribing practices and efforts to increase MOUD access
ORN Fall 2023 - Update on the U.S. Overdose Crisis: Which drugs, who is dying, and how do we save lives?
ORN Fall 2022 #1 - Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl
ORN Fall 2022 #2 - Case Studies and Q/A - Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl
ORN Fall 2022 #3 - Managing Opioid Complexity in Individuals with Serious Illness
ORN Fall 2022 #4 - Case Studies and Q/A - Managing Opioid Complexity in Individuals with Serious Illness
ORN Fall 2022 #5 - The State of Harm Reduction in the US: Progress, Barriers, and What's Next
ORN Fall 2022 #6 - Case Studies and Q/A - The State of Harm Reduction in the US: Progress, Barriers, and What's Next
ORN Spring 2022 #1 - The impact of illicit fentanyl use on opioid use disorder treatment
ORN Spring 2022 #2 - Case Studies and QandA: The impact of illicit fentanyl use on opioid use disorder treatment
ORN Spring 2022 #3 - Drugs, Stigma, and Health
ORN Spring 2022 #4 - Case Studies and QandA: Drugs, Stigma, and Health
ORN Spring 2022 #5 - The Fourth Wave: Addressing the Intertwined Fentanyl and Stimulant Overdose Crisis
ORN Spring 2022 #6 - Case Studies and QandA: The Fourth Wave: Addressing the Intertwined Fentanyl and Stimulant Overdose Crisis
Public Health Implications of Expanded Marijuana Programs
BAD MEDICINE: Mental Health and What the Opioid Epidemic Can Teach Us About Cannabis
Student Osteopathic Medical Association (SOMA) - The 8-hour MOUD Training - PART 1 - 11/18/2023 (counts towards the DEA’s 8-hour training requirement)
Cannabis and Adolescent Brain Development
Negative Impacts of High Potency THC on the Developing Brain and Mental Health - This Is NOT "Medicine"
ORN Spring 2024 - Maternal Morbidity and Mortality Associated with Methamphetamine and Other Substance Use in the Perinatal Period
ORN Spring 2024 - Opioid Use Disorder in Youth
ORN Spring 2024 - Psychostimulant Toxicity
ORN Spring 2024 - Exploring the Interface of Cannabis, Cannabinoids, and Opioid Use Disorder: Clinical Insights and Emerging Research
ORN Spring 2024 - ED Treatment of Opioid Use Disorder: Truth, Trends and Treatments
ORN Spring 2024 - Opioid Prescribing by Dentists and Oral Maxillofacial Surgeons
Cognitive Behavior Therapy Skills for Healthcare Providers
Mutual Help Groups for Addiction
Motivational Interviewing - Practices from the Heart
Contingency Management for the Treatment of Substance Use Disorders
The 8-hour MOUD Training - PART 1 - 5/18/2024
ORN Summer 2024 - Xylazine Wound Care Clinic and Protocol
ORN Summer 2024 - Clinical Implications of the Relationship Between Naltrexone Plasma Levels and the Subjective Effects of Heroin in Humans
ORN Summer 2024 - Extended-Release Buprenorphine
ORN Summer 2024 - Kratom Consumers in the United States: What clinicians need to know
ORN Summer 2024 - Hepatitis C Virus in Pregnancy: An Opportunity to Screen and Treat
ORN Summer 2024 - BUGS AND DRUGS: Case-Based Pearls for Addiction Consultants Treating People Who Use Drugs Hospitalized with Infections
Situating Harm Reduction Along the Continuum of Care for People with Substance Use Disorder
2024 Addiction Medicine Board Certification Review Course
4-hour Live MOUD Training - 2/15/2025
ORN Spring 2025 - Peer-Assisted Telemedicine for Hepatitis C (PATHS)
ORN Spring 2025 - A novel prolonged exposure therapy protocol for improving therapy session attendance and PTSD symptoms among adults receiving buprenorphine or methadone
ORN Spring 2025 - Barriers to Substance Use Treatment Among People Who Use Drugs in the Rural United States: A Qualitative, Multi-Site Study
ORN Spring 2025 - Case Reports - Diagnosis and Treatments
ORN Spring 2025 - Evaluation of methamphetamine assist packs: As-needed antipsychotics for self-management of methamphetamine-associated psychiatric toxicity
ORN Spring 2025 - GLP-1 receptor agonists for the treatment of substance use disorders: A review
4-hour Live MOUD Training - 5/3/2025
4-hour Live MOUD Training - 8/9/2025
Crystal methamphetamine: Exposure Effects on Pregnancy, Fetal Development, Delivery, Infancy, and Childhood
Disclaimer
Disclaimer
Credit Statement
Credit Statement - AOA Category 1-A
AVAILABLE ON-DEMAND
Claim Credits & Course Materials
Instructions and Claiming CME
Funding
ORN Funding
ACCREDITATION STATEMENTS
CME
CME
What is ORN